These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
536 related articles for article (PubMed ID: 23490908)
1. Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection. Passoni NM; Abdollah F; Suardi N; Gallina A; Bianchi M; Tutolo M; Fossati N; Gandaglia G; Salonia A; Freschi M; Rigatti P; Montorsi F; Briganti A Urol Oncol; 2014 Jan; 32(1):29.e21-8. PubMed ID: 23490908 [TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184 [TBL] [Abstract][Full Text] [Related]
3. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study. Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833 [TBL] [Abstract][Full Text] [Related]
4. Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era. Dorin RP; Lieskovsky G; Fairey AS; Cai J; Daneshmand S Urol Oncol; 2013 Nov; 31(8):1441-7. PubMed ID: 22516714 [TBL] [Abstract][Full Text] [Related]
5. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy. Briganti A; Karnes JR; Da Pozzo LF; Cozzarini C; Gallina A; Suardi N; Bianchi M; Freschi M; Doglioni C; Fazio F; Rigatti P; Montorsi F; Blute ML Eur Urol; 2009 Feb; 55(2):261-70. PubMed ID: 18838212 [TBL] [Abstract][Full Text] [Related]
6. Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement. Godoy G; Chong KT; Cronin A; Vickers A; Laudone V; Touijer K; Guillonneau B; Eastham JA; Scardino PT; Coleman JA Eur Urol; 2011 Aug; 60(2):195-201. PubMed ID: 21257258 [TBL] [Abstract][Full Text] [Related]
7. More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer. Abdollah F; Gandaglia G; Suardi N; Capitanio U; Salonia A; Nini A; Moschini M; Sun M; Karakiewicz PI; Shariat SF; Montorsi F; Briganti A Eur Urol; 2015 Feb; 67(2):212-9. PubMed ID: 24882672 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years. Suardi N; Gandaglia G; Gallina A; Di Trapani E; Scattoni V; Vizziello D; Cucchiara V; Bertini R; Colombo R; Picchio M; Giovacchini G; Montorsi F; Briganti A Eur Urol; 2015 Feb; 67(2):299-309. PubMed ID: 24571959 [TBL] [Abstract][Full Text] [Related]
9. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer. Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441 [TBL] [Abstract][Full Text] [Related]
10. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes. Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Montorsi F; Graefen M; Shariat SF; Saad F; Briganti A; Karakiewicz PI Eur Urol Oncol; 2019 Sep; 2(5):541-548. PubMed ID: 31411992 [TBL] [Abstract][Full Text] [Related]
12. Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis. Kim KH; Lim SK; Kim HY; Shin TY; Lee JY; Choi YD; Chung BH; Hong SJ; Rha KH BJU Int; 2013 Jul; 112(2):216-23. PubMed ID: 23356436 [TBL] [Abstract][Full Text] [Related]
13. Lymph node dissection during robotic-assisted laparoscopic prostatectomy: comparison of lymph node yield and clinical outcomes when including common iliac nodes with standard template dissection. Katz DJ; Yee DS; Godoy G; Nogueira L; Chong KT; Coleman JA BJU Int; 2010 Aug; 106(3):391-6. PubMed ID: 20089113 [TBL] [Abstract][Full Text] [Related]
14. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection. Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120 [TBL] [Abstract][Full Text] [Related]
15. Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score. Schiavina R; Borghesi M; Brunocilla E; Manferrari F; Fiorentino M; Vagnoni V; Baccos A; Pultrone CV; Rocca GC; Rizzi S; Martorana G BJU Int; 2013 Jun; 111(8):1237-44. PubMed ID: 23331345 [TBL] [Abstract][Full Text] [Related]
16. Disease-specific survival after radical lymphadenectomy for penile cancer: prediction by lymph node count and density. Li ZS; Yao K; Chen P; Zou ZJ; Qin ZK; Liu ZW; Li YH; Zhou FJ; Han H Urol Oncol; 2014 Aug; 32(6):893-900. PubMed ID: 24994488 [TBL] [Abstract][Full Text] [Related]
17. Extended pelvic lymph node dissection including internal iliac packet should be performed during robot-assisted laparoscopic radical prostatectomy for high-risk prostate cancer. Jung JH; Seo JW; Lim MS; Lee JW; Chung BH; Hong SJ; Song JM; Rha KH J Laparoendosc Adv Surg Tech A; 2012 Oct; 22(8):785-90. PubMed ID: 22967037 [TBL] [Abstract][Full Text] [Related]
18. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer. Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148 [TBL] [Abstract][Full Text] [Related]
19. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Briganti A; Larcher A; Abdollah F; Capitanio U; Gallina A; Suardi N; Bianchi M; Sun M; Freschi M; Salonia A; Karakiewicz PI; Rigatti P; Montorsi F Eur Urol; 2012 Mar; 61(3):480-7. PubMed ID: 22078338 [TBL] [Abstract][Full Text] [Related]